Hyloris Pharmaceuticals SA (EBR:HYL)
4.300
+0.050 (1.18%)
Nov 19, 2026, 5:36 PM CET
| Market Cap | 120.40M -28.3% |
| Revenue (ttm) | 9.83M +16.2% |
| Net Income | -4.65M |
| EPS | -0.17 |
| Shares Out | 28.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,205 |
| Open | 4.250 |
| Previous Close | 4.250 |
| Day's Range | 4.140 - 4.300 |
| 52-Week Range | 3.320 - 8.400 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 11.23 (+161.16%) |
| Earnings Date | Mar 25, 2027 |